Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gutgesell

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Endocrine-Related Cancer|November 19, 2025
GLP1 receptor agonism alters growth and therapeutic response in prostate cancerSoumen Bera, Lisa C Gutgesell, Brynne Darden, et al.
Oncogene|February 11, 2022
Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cellsLarischa de Wet, Anthony Williams, Marc Gillard, et al.
Oncogene|January 24, 2022
SOX2 mediates metabolic reprogramming of prostate cancer cellsLarischa de Wet, Anthony Williams, Marc Gillard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2024
ERBB3 Overexpression is Enriched in Diverse Patient Populations with Castration-sensitive Prostate Cancer and is Associated with a Unique AR Activity SignatureJordan E Vellky, Brenna J Kirkpatrick, Lisa C Gutgesell, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Endocrine-Related Cancer|November 19, 2025
GLP1 receptor agonism alters growth and therapeutic response in prostate cancerSoumen Bera, Lisa C Gutgesell, Brynne Darden, et al.
Oncogene|February 11, 2022
Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cellsLarischa de Wet, Anthony Williams, Marc Gillard, et al.
Oncogene|January 24, 2022
SOX2 mediates metabolic reprogramming of prostate cancer cellsLarischa de Wet, Anthony Williams, Marc Gillard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2024
ERBB3 Overexpression is Enriched in Diverse Patient Populations with Castration-sensitive Prostate Cancer and is Associated with a Unique AR Activity SignatureJordan E Vellky, Brenna J Kirkpatrick, Lisa C Gutgesell, et al.
Pageof 3